Abstract
Adoptive transfer of regulatory T (Treg) cells could be an alternative to chronic immunosuppression for prevention of allogeneic graft rejection. While polyspecific Treg cells can prevent immune responses under lymphopenic conditions, Ag-specific Treg cells are needed to treat autoimmunity and graft rejection. Yet, reliable markers for Ag-specific Treg cells are missing. We report that latency-associated peptide (LAP) and glycoprotein A repetitions predominant (GARP) can identify human Ag-specific Treg cells. In addition, we show that the depletion of CD154+ cells from LAP+ or GARP+ Treg cells increases the Treg-cell purity to over 90%, as assessed by epigenetic analysis. These Ag-specific Treg cells can be isolated magnetically andmight contribute to the development of GMP-based protocols. In addition, Ag-specific Treg cells are functionally far superior to CD4+CD25high or CD4+CD25highCD127low Treg cells in vitro and in preventing strong alloreactions in humanized mice. They could, therefore, have a high therapeutic potential for the control of alloimmune, autoimmune, and allergic immune responses in patients.
Author supplied keywords
Cite
CITATION STYLE
Noyan, F., Lee, Y. S., Zimmermann, K., Hardtke-Wolenski, M., Taubert, R., Warnecke, G., … Jaeckel, E. (2014). Isolation of human antigen-specific regulatory T cells with high suppressive function. European Journal of Immunology, 44(9), 2592–2602. https://doi.org/10.1002/eji.201344381
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.